🔹 HEG: Its subsidiary TACC signs an agreement with INOXAP for nitrogen supply and operation of a nitrogen plant at its Madhya Pradesh facility.

🔹 3M India: Concludes an Advance Pricing Agreement (APA) with the CBDT and records a tax expense of ₹171 crore in its profit & loss account.

🔹 RVNL: Secures a ₹270 crore project from Central Railway.

🔹 Datamatics Global Services: Its Netherlands-based step-down subsidiary has been liquidated, effective February 18.

🔹 Intellect Design Arena: Its Purple Fabric platform wins a strategic mandate from a leading Indian financial services group.

🔹 Afcons Infrastructure: A client terminates a €113 million road project contract; the company is pursuing legal remedies for pending dues.

🔹 Dr. Reddy’s Laboratories: The US SEC concludes its probe into alleged payments in Ukraine and recommends no enforcement action.

🔹 Hexaware Technologies: Expands its partnership with AWS to deliver AI-enabled software development lifecycle solutions.

🔹 Exide Industries: Invests ₹100 crore in its subsidiary, Exide Energy Solutions.

🔹 Hindalco Industries: Its arm AV Minerals plans to purchase 13.3 lakh shares of the company for $200 million.

🔹 Waaree Energies: Its subsidiary receives a Letter of Award from SECI for a 300 MW wind power project in Gujarat.

🔹 SAMHI Hotels: Its arm receives approval to develop a second hotel property in Bengaluru with 235 rooms.

🔹 WeWork India: Signs an agreement to add 1.6 lakh sq ft in Pune, with an investment of ₹36 crore.

🔹 JSW Energy: Receives NSE and BSE approval for listing of 95 lakh shares allotted on a preferential basis.

🔹 Lupin: Secures US FDA approval for Brivaracetam Oral Solution and launches the product in the US market.

🔹 Lemon Tree Hotels: Signs a license agreement for a new 100-room hotel in Uttar Pradesh.

🔹 HG Infra Engineering: Emerges as L1 bidder for an NHAI project worth ₹1,582 crore.

🔹 HealthCare Global (HCG): Plans to issue 82.9 lakh shares at ₹512 per share.

🔹 Persistent Systems: Clarifies there is no imminent M&A deal but continues to evaluate inorganic growth opportunities.

🔹 Utkarsh Small Finance Bank: Schedules a creditors’ meeting on March 28 to approve its merger with Utkarsh CoreInvest.

🔹 Biocon: Receives US FDA approval for Liraglutide, a drug-device combination for weight management.

🔹 Apollo Pipes: Acquires an additional 3.34% stake in subsidiary Kisan Mouldings for ₹9.8 crore.

🔹 5paisa Capital: Plans to raise up to ₹475 crore through a rights issue.

Disclaimer:

This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.

Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.